André Abrahão is an accomplished Medical Director and Chief Medical Officer with extensive experience in the pharmaceutical industry, having worked in both Brazil and France. Previously, André held significant roles at Merck Group and Novartis, leading initiatives in medical governance, strategic planning, and clinical research within various therapeutic areas. Currently serving as the Medical Affairs Director at Gilead Sciences, André is responsible for overseeing multiple therapeutic areas, including Virology and Oncology, while also driving medical excellence and governance in Brazil. André's educational background includes a PhD in Neurosciences and multiple postgraduate degrees in related fields.
This person is not in any teams
This person is not in any offices